Nerves Electrify Stomach Cancer, Sparking Growth and Spread

When sensory neurons (red) are cultured with stomach cancer organoids (yellow), the neuron and cancer cells create connections that resemble synapses and establish an electrical circuit among the cells. Images provided by Timothy Wang / Columbia University Vagelos College of Physicians and Surgeons.
Researchers have discovered that stomach cancers in mice make electrical connections with nearby sensory nerves and use these malignant circuits to stimulate the cancer’s growth and spread.
It is the first time that electrical contacts between nerves and a cancer outside the brain have been found, raising the possibility that many other cancers progress by making similar connections.
“We know that many cancers exploit nearby neurons to fuel their growth, but outside of cancers in the brain, these interactions have been attributed to the secretion of growth factors broadly or through indirect effects,” says Timothy Wang, the Silberberg Professor of Medicine at Columbia University Vagelos College of Physicians and Surgeons, who led the study and is one of the leaders in the growing field of cancer neuroscience.
“Now that we know the communication between the two is more direct and electrical, it raises the possibility of repurposing drugs designed for neurological conditions to treat cancer.”
The wiring of neurons to cancer cells also suggests that cancer can commandeer a particularly rapid mechanism to stimulate growth.
“There are many different cells surrounding cancers, and this microenvironment can sometimes provide a rich soil for their growth,” Wang says. Researchers have been focusing on the role of the microenvironment’s immune cells, connective tissue, and blood vessels in cancer growth but have only started to examine the role of nerves in the last two decades.
“What’s emerged recently is how advantageous the nervous system can be to cancer,” Wang adds. “The nervous system works faster than any of these other cells in the tumor microenvironment, which allows tumors to more quickly communicate and remodel their surroundings to promote their growth and survival.”
Cancer-neuron connections resemble synapses
As a gastroenterologist, Wang’s research has focused on stomach and other GI cancers. About 10 years ago, he discovered that cutting the vagus nerve in mice with stomach cancer significantly slowed tumor growth and increased survival rate.
Many different types of neurons are contained in the vagus nerve, but the researchers focused here on sensory neurons, which reacted most strongly to the presence of stomach cancer in mice. Some of these sensory neurons extended themselves deep into stomach tumors in response to a protein released by cancer cells called Nerve Growth Factor (NGF), drawing the cancer cells close to the neurons. After establishing this connection, tumors signaled the sensory nerves to release the peptide Calcitonin Gene Related Peptide (CGRP), inducing electrical signals in the tumor.
Though the cancer cells and neurons may not form classical synapses where they meet—the team’s electron micrographs are still a bit fuzzy—“there’s no doubt that the neurons create an electric circuit with the cancer cells,” Wang says. “It's a slower response than a typical nerve-muscle synapse, but it's still an electrical response.”
The researchers could see this electrical activity with calcium imaging, a technique that uses fluorescent tracers that light up when calcium ions surge into a cell as an electrical impulse travels through.
“There’s a circuit that starts from the tumor, goes up toward the brain, and then turns back down toward the tumor again,” Wang says. It’s like a feed-forward loop that keeps stimulating the cancer and promoting its growth and spread.”
Migraine drugs as a potential cancer treatment
For stomach cancer, CGRP inhibitors that are currently used to treat migraines could potentially short-circuit the electrical connection between tumors and sensory neurons.
In Wang’s study, CGRP inhibitors administered to mice with stomach cancer reduced the size of the tumors, prolonged survival, and prevented the tumors from spreading.
“Based on our analysis of stomach cancer data from patients, we believe that the circuits we’ve found in mice also exist in humans and targeting them could be an additional useful therapy,” Wang says.
Sensory neurons may also use CGRP to stimulate cancer through more indirect pathways. Unpublished findings from Wang’s lab suggest that the neurons promote stomach cancer growth via contact with connective tissue cells in the tumor microenvironment. And other researchers have found that sensory nerves may, possibly through CGRP, cause T cell exhaustion and turn off immune responses directed at other types of cancers.
“But we think it all starts with the cancer cell setting up a neural circuit,” Wang says.
“Nerves are an underappreciated master regulator of normal growth and regeneration in animals. We know that when organs form during development, the nerves lead the way. From that point of view, it was not unexpected that nerves would be driving tumor growth as well.”
References
Additional information
Timothy Wang, MD, is also the chief of the Division of Digestive and Liver Diseases at Columbia University Vagelos College of Physicians and Surgeons and is a member of Columbia’s Herbert Irving Comprehensive Cancer Center.
The study, “Nociceptive neurons promote gastric tumor progression via a CGRP/Ramp1 axis," was published online Feb. 19, 2025.
All authors (from Columbia unless noted): Xiaofei Zhi (now at Affiliated Hospital of Nantong University, China), Feijing Wu, Jin Qian, Yosuke Ochiai, Guodong Lian, Ermanno Malagola, Biyun Zheng (Columbia and Fujian Medical University Union Hospital, China), Ruhong Tu, Yi Zeng, Hiroki Kobayashi, Zhangchuan Xia, Ruizhi Wang, Yueqing Peng, Qiongyu Shi, Duan Chen (Norwegian University of Science and Technology), Sandra W Ryeom, and Timothy C Wang.
This work was supported by grants from the NIH (UO1DK103155, R01DK128195, R01CA272901, R01CA224428, R35CA210088, R01CA272891 and P50CA127003); NIH/NCI Cancer Center Support Grant P30CA013696 and resources of the Herbert Irving Comprehensive Cancer Center (Flow Cytometry Shared Resources, Molecular Pathology, Genomics and High Throughput Screening, the Oncology Precision Therapeutics and Imaging Core, and the Genetically Modified Mouse Model Shared Resource); and the Columbia University Digestive and Liver Disease Research Center (NIH grant P30DK132710) and its Bio-Imaging, Organoid, and Bioinformatics/Single-Cell Analysis Cores.
The authors declare that they have no competing interests.